brain2“The brain is more than an assemblage of autonomous modules, each crucial for a specific mental function. Every one of these functionally specialized areas must interact with dozens or hundreds of others, their total integration creating something like a vastly complicated orchestra with thousands of instruments, an orchestra that conducts itself, with an ever-changing score and repertoire.”

- Oliver Sacks: The Mind’s Eye


Please see Synapse for updated information about the Consortium

The CommonMind Consortium has as a goal to generate and analyze large scale data from human subjects with neuropsychiatric and neurodevelopmental disorders and to make this data and the analytical results broadly available to the public as a free resource.

As many as 450 million people worldwide are believed to be living with a mental or behavioral disorder: schizophrenia and bipolar disorder are two of the top six leading causes of years lived with disability according to the World Health Organization. The burden on the individual as well as on society is significant with estimates for the health care costs for these individuals as high as four percent GNP. This highlights a grave need for new therapies to alleviate suffering.

Brain2Technology has reached a level of maturity where generation of large scale molecular data is feasible, enabling a better understanding of the molecular underpinnings of these disorders. CommonMind consists of a multi-faceted team with expertise in the generation, management, and analysis of this data.

We believe the goal of developing new therapies for neuropsychiatric and neurodevelopmental disorders is best met by pooling resources and knowledge, by sharing data and analysis, and ultimately by providing a publically available resource for the entire community